×
About 3,668 results

ALLMedicine™ Bulimia Nervosa Center

Research & Reviews  1,187 results

Psychopharmacologic Management of Eating Disorders.
https://doi.org/10.1007/s11920-022-01340-5 10.1007/s40519-016-0264-x 10.1097/YCO.0000000000000641 10.1002/eat.23486 10.1159/000350058 10.1001/archpsyc.57.7.659 10.1186/s40337-020-00348-7 10.1097/YCO.0000000000000358 10.1017/S1461145711000460 10.1007/s00228-017-2287-2 10.1007/s40519-016-0253-0 10.1186/s40337-015-0040-8 10.1002/eat.22501 10.1016/S0140-6736(04)17669-1 10.1016/j.clinthera.2020.11.006 10.1007/s00431-018-3295-7 10.1001/archpsyc.1991.01810320036006 10.1007/s10578-007-0086-1 10.1176/appi.ajp.161.12.2215 10.1016/j.psc.2019.01.007 10.3109/15622975.2011.602720 10.9740/mhc.2018.05.127 10.1176/ajp.155.4.548 10.1001/jama.295.22.2605 10.1002/eat.10235 10.1016/j.pharmthera.2020.107667 10.1002/erv.988 10.1176/appi.ajp.2008.07121900 10.1159/000369978 10.1017/S0033291711000390 10.1016/j.appet.2010.05.090 10.1037/a0031823 10.1002/eat.23589 10.1002/eat.22343 10.1007/s40519-018-0619-6 10.1016/j.amjmed.2015.06.031 10.1016/j.psc.2019.01.009 10.4103/0019-5545.64596 10.1002/eat.20372 10.1001/archpsyc.1992.01820020059008 10.1176/appi.ajp.159.1.96 10.1089/104454603322572660 10.1016/j.genhosppsych.2008.02.002 10.4088/JCP.v64n1208 10.4088/JCP.v64n1109 10.1002/eat.20202 10.1002/eat.22452 10.1016/j.psc.2019.01.010 10.1111/nyas.13467 10.4088/JCP.sh16003su1c.03 10.1016/j.eatbeh.2007.03.006 10.4088/JCP.v67n1209 10.4088/JCP.v65n0108 10.1176/appi.ajp.160.2.255 10.4088/JCP.v65n1104 10.1016/j.biopsych.2006.08.008 10.1080/17512433.2018.1383895 10.1001/jamapsychiatry.2014.2162 10.1002/erv.2418 10.1001/jamapsychiatry.2017.1889 10.4088/JCP.v68n0306
Current Psychiatry Reports; Muratore AF, Attia E

May 17th, 2022 - Identifying medications that may be used as therapeutic agents for eating disorders is a longstanding focus of research, with varying degrees of success. The present review consolidates the most recent findings on pharmacological treatment of thre...

Striae distensae as a diagnostic indicator for eating disorder pathologies.
https://doi.org/10.1111/ijd.16223
International Journal of Dermatology; Silva V, Schukow CP et. al.

May 12th, 2022 - This manuscript provides a review of the relationship between patients with an underlying eating disorder (ED) and the presence of striae distensae (SD). Researchers and clinicians have recognized many different skin manifestations associated with...

Prevalence of diagnosed eating disorders in US transgender adults and youth in insuranc...
https://doi.org/10.1002/eat.23729
The International Journal of Eating Disorders; Ferrucci KA, Lapane KL et. al.

May 8th, 2022 - We estimated the prevalence of diagnosed eating disorders, overall and by select demographics, among commercially insured individuals identified as transgender in a national claims database. From the 2018 IBM® MarketScan® Commercial Database, ther...

Genetics and neurobiology of eating disorders.
https://doi.org/10.1038/s41593-022-01071-z 10.1097/YCO.0000000000000276 10.1016/S2215-0366(21)00040-7 10.1017/S0033291718001472 10.1016/j.pbiomolbio.2007.07.019 10.1016/j.jpsychires.2010.10.003 10.1038/s41588-019-0439-2 10.1176/appi.ajp.2017.16121402 10.1016/j.cct.2018.09.015 10.3390/genes12040491 10.1111/adb.12880 10.1176/appi.ajp.161.12.2215 10.1002/wps.20251 10.1111/sltb.12235 10.1002/da.20834 10.1038/ng.3406 10.1192/bjp.2019.39 10.1016/j.jaac.2018.11.008 10.3390/jcm9041187 10.1002/eat.23481 10.1001/jamapsychiatry.2020.3042 10.1111/jcpp.12295 10.1016/j.cell.2019.11.020 10.1016/j.neulet.2017.04.054 10.1038/s41380-018-0115-4 10.1001/jama.2016.1975 10.1038/s41386-020-00847-w 10.1038/mp.2013.91 10.1371/journal.pone.0181556 10.1172/JCI71400 10.1097/YPG.0000000000000224 10.1038/mp.2010.107 10.1097/YPG.0000000000000172 10.1038/mp.2013.187 10.1016/j.jpsychires.2019.01.021 10.1186/s12888-021-03212-3 10.1002/wdev.375 10.1093/hmg/ddy271 10.1016/j.neuron.2019.01.022 10.1038/nn.4590 10.1038/nrc1319 10.1126/science.abb9032 10.1038/s41586-021-03468-5 10.1038/ng.3404 10.1038/s41588-018-0129-5 10.1093/cercor/bhy283 10.3389/fnbeh.2016.00054 10.1126/science.aat8464 10.1016/j.cmet.2017.09.021 10.1016/j.neuropharm.2013.03.019 10.1016/j.biopsych.2011.05.028 10.1176/appi.ajp.2019.19030261 10.1002/eat.20869 10.1093/scan/nsw049 10.1016/j.biopsych.2006.07.018 10.1016/j.pscychresns.2015.06.013 10.1002/eat.20937 10.1002/eat.20984 10.1038/s41598-020-63389-7 10.1176/appi.ajp.2013.12101294 10.1038/nrn2555 10.1038/npp.2015.174 10.1097/PSY.0000000000000510 10.1038/s41386-019-0361-4 10.1016/j.conb.2011.04.010 10.1176/appi.ajp.2011.11010094 10.1503/jpn.150335 10.1371/journal.pone.0092017 10.1002/eat.20750 10.1016/j.pscychresns.2021.111379 10.1016/j.jaac.2021.04.019 10.1001/jamapsychiatry.2014.2206 10.1176/appi.ajp.2019.18111271 10.1176/appi.ajp.2015.15060725 10.1503/jpn.180162 10.1093/schbul/sby046 10.1016/j.biopsych.2006.03.040 10.1002/eat.22829 10.1503/jpn.180121 10.1038/s41398-020-0705-1 10.1016/j.euroneuro.2006.04.007 10.1016/j.euroneuro.2009.10.001 10.1371/journal.pone.0050453 10.1016/j.physbeh.2018.09.013 10.1038/s41598-019-51874-7 10.1016/j.biopsych.2016.10.021 10.1534/g3.119.400470 10.1038/s41398-020-0725-x 10.1038/s41598-018-25548-9 10.1002/pmic.201700395 10.1016/j.nut.2019.110557 10.1038/s41467-018-03836-2 10.1038/npp.2015.354 10.1002/mnfr.201500815 10.1016/j.tem.2017.02.006 10.1002/syn.21837 10.1016/j.neuron.2017.06.014 10.1038/s41380-019-0633-8 10.1016/j.biopsych.2020.06.022 10.3389/fpsyt.2021.711181 10.1038/npp.2017.63 10.1038/sj.mp.4001909 10.1016/j.euroneuro.2010.11.006 10.1523/JNEUROSCI.2521-12.2012 10.1016/j.biopsych.2016.06.005 10.1073/pnas.1909340117 10.1073/pnas.1712214114 10.1523/JNEUROSCI.3237-12.2013 10.1523/JNEUROSCI.2693-17.2018 10.1038/nature22375 10.1073/pnas.1416573112 10.1016/j.appet.2018.11.011 10.1038/s41467-020-14281-5 10.1038/s41386-019-0538-x 10.1038/s41386-019-0394-8 10.1172/jci.insight.126283 10.1038/s41593-018-0209-y 10.3389/fnut.2019.00118 10.1038/nn.4411 10.1093/ajcn/nqy342 10.1192/bjp.bp.108.054742 10.1001/jamapsychiatry.2015.2737 10.1002/eat.22736 10.1176/appi.ajp.2007.06081388 10.7326/M15-2455 10.2147/NDT.S109637 10.1037/h0062565 10.3389/fnut.2019.00069 10.3390/nu10010071 10.1093/ilar.53.1.23 10.1038/npp.2016.269 10.1016/j.pharep.2014.11.012 10.1152/ajpregu.90309.2008 10.1016/j.bbr.2016.03.046
Nature Neuroscience; Bulik CM, Coleman JRI et. al.

May 7th, 2022 - Eating disorders (anorexia nervosa, bulimia nervosa and binge-eating disorder) are a heterogeneous class of complex illnesses marked by weight and appetite dysregulation coupled with distinctive behavioral and psychological features. Our understan...

Retention, engagement, and binge-eating outcomes: Evaluating feasibility of the Binge-E...
https://doi.org/10.1002/eat.23726
The International Journal of Eating Disorders; Flatt RE, Thornton LM et. al.

May 4th, 2022 - Using preliminary data from the Binge-Eating Genetics Initiative (BEGIN), we evaluated the feasibility of delivering an eating disorder digital app, Recovery Record, through smartphone and wearable technology for individuals with binge-type eating...

see more →

Guidelines  1 results

Screening for Eating Disorders in Adolescents and Adults: US Preventive Services Task F...
https://doi.org/10.1001/jama.2022.1806
JAMA , Davidson KW et. al.

Mar 16th, 2022 - Eating disorders (eg, binge eating disorder, bulimia nervosa, and anorexia nervosa) are a group of psychiatric conditions defined as a disturbance in eating or eating-related behaviors that impair physical or psychosocial functioning. According to...

see more →

Drugs  171 results see all →

Clinicaltrials.gov  37 results

Neurobiology of Bulimia Nervosa
https://clinicaltrials.gov/ct2/show/NCT04225221

Apr 28th, 2022 - Eating disorders (EDs) affect 15 million women in the United States and have one of the highest mortality rates of any mental illness. Despite this, the underlying neurobiology remains poorly understood. EDs predominantly occur in women, and the f...

FAMily Factors INvolved in Eating Disorders
https://clinicaltrials.gov/ct2/show/NCT05339165

Apr 21st, 2022 - Study participants are recruited (300 patients for each entity). Healthy subjects without evidence of an eating disorder serve as a control group. Psychometric assessment will include data on pathological eating behavior and general psychological ...

Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa
https://clinicaltrials.gov/ct2/show/NCT04917068

Apr 14th, 2022 - Bulimia nervosa (BN), an eating disorder characterized by recurrent bulimic episodes of binge eating and often persists in spite of treatment, likely indicating ineffectively targeted maintenance mechanisms. Treatment outcome data suggest that < 3...

Inhibitory Control and Eating Disorders
https://clinicaltrials.gov/ct2/show/NCT03850288

Mar 22nd, 2022 - Executive functions are part of the high-level cognitive processes essential to the proper functioning of human cognition. They consist mainly of flexibility, updating and inhibition. Some studies have shown a correlation between executive disorde...

The Effect of iTBS on the Inhibition Control Function of BN
https://clinicaltrials.gov/ct2/show/NCT05186441

Jan 11th, 2022 - Bulimia nervosa(BN) is a chronic and refractory mental disorder characteristic of recurrent binge eating and weight control which mostly occur in adolescents and young women. The life-time prevalence ranges from 1.0%-4.2%, and keep increasing. Pat...

see more →

News  65 results

Jury Is Out on Universal Screening for Eating Disorders
https://www.medscape.com/viewarticle/970681

Mar 22nd, 2022 - There is insufficient evidence to weigh the balance of benefits and harms of screening for eating disorders in adolescents and adults, the US Preventive Services Task Force (USPSTF) says in their first-ever statement on the topic. Eating disorders...

Eating Disorders Peaked in COVID; Depression in Residency; DMT Trial Pending
https://www.medpagetoday.com/psychiatry/generalpsychiatry/95732

Nov 17th, 2021 - During the pandemic, inpatient care for eating disorders -- including anorexia nervosa, bulimia nervosa, and others -- doubled by May 2020. "The pandemic may have promoted disordered eating behaviors among susceptible individuals," the researchers...

COVID Lockdowns Linked to PTSD in Patients With Eating Disorders
https://www.medscape.com/viewarticle/950068

Apr 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 and its resulting lockdowns are linked to posttraumatic stress disorder (PTSD) symptoms and other adverse outcomes among patients with ea...

'Stunning' Report Shows Eating Disorders Are Vastly Underestimated
https://www.medscape.com/viewarticle/947173

Mar 10th, 2021 - A "stunning" new analysis of global data on eating disorders show that they are far more prevalent and disabling than previously reported. Investigators found the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 underestimate...

Certifying Medical Cannabis: What APRNs Need to Know
https://www.medscape.com/viewarticle/943249

Jan 5th, 2021 - A patient asks an advanced practice registered nurse (APRN) to approve them for "medical marijuana." What are the clinician's responsibilities? The first hurdle is legal. In 18 states, an APRN has the legal authority to certify a patient to use ma...

see more →

Patient Education  6 results see all →